Guidelines for the pharmacological treatment of peripheral neuropathic pain
Neuropathic pain (NeP) has been the focus of extensive basic and clinical research over the past 20 years. This has led to an increased understanding of underlying pathophysiological mechanisms and the development of new therapeutic agents, as well as a clearer definition of the role of established...
Saved in:
| Main Author: | |
|---|---|
| Other Authors: | , , , , , , , |
| Format: | article |
| Published: |
2010
|
| Online Access: | http://hdl.handle.net/10725/10511 https://doi.org/10.1177/147323001003800201 http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php https://journals.sagepub.com/doi/abs/10.1177/147323001003800201 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1864513486662402048 |
|---|---|
| author | Riachi, N. |
| author2 | Bohlega, S. Alsaadi, T. Amir, A. Hosny, H. Karawagh, A.M. Moulin, D. Salti, A. Shelbaya, S. |
| author2_role | author author author author author author author author |
| author_facet | Riachi, N. Bohlega, S. Alsaadi, T. Amir, A. Hosny, H. Karawagh, A.M. Moulin, D. Salti, A. Shelbaya, S. |
| author_role | author |
| dc.creator.none.fl_str_mv | Riachi, N. Bohlega, S. Alsaadi, T. Amir, A. Hosny, H. Karawagh, A.M. Moulin, D. Salti, A. Shelbaya, S. |
| dc.date.none.fl_str_mv | 2010 2019-04-30T12:53:14Z 2019-04-30T12:53:14Z 2019-04-30 |
| dc.identifier.none.fl_str_mv | 1473-2300 http://hdl.handle.net/10725/10511 https://doi.org/10.1177/147323001003800201 Bohlega, S., Alsaadi, T., Amir, A., Hosny, H., Karawagh, A. M., Moulin, D., ... & Shelbaya, S. (2010). Guidelines for the pharmacological treatment of peripheral neuropathic pain: expert panel recommendations for the middle East region. Journal of International Medical Research, 38(2), 295-317. http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php https://journals.sagepub.com/doi/abs/10.1177/147323001003800201 |
| dc.language.none.fl_str_mv | en |
| dc.relation.none.fl_str_mv | Journal of International Medical Research |
| dc.rights.*.fl_str_mv | info:eu-repo/semantics/openAccess |
| dc.title.none.fl_str_mv | Guidelines for the pharmacological treatment of peripheral neuropathic pain expert panel recommendations for the middle east region |
| dc.type.none.fl_str_mv | Article info:eu-repo/semantics/publishedVersion info:eu-repo/semantics/article |
| description | Neuropathic pain (NeP) has been the focus of extensive basic and clinical research over the past 20 years. This has led to an increased understanding of underlying pathophysiological mechanisms and the development of new therapeutic agents, as well as a clearer definition of the role of established medications. To date there are no published treatment guidelines for NeP in the Middle East. A multidisciplinary panel of Middle East and international experts met to review critically and reach a consensus on how best to apply evidence-based guidelines for the treatment of NeP (mainly peripheral NeP) in the Middle East. The expert panel recommended pregabalin, gabapentin and secondary amine tricyclic antidepressants (nortriptyline and desipramine) as first-line treatments for peripheral NeP. Serotonin-norepinephrine reuptake inhibitor antidepressants, tramadol and controlled-release opioid analgesics were recommended as second-line treatments. There is a need to increase diagnostic awareness of NeP, use validated screening questionnaires and undertake more treatment research in the Middle East region. |
| eu_rights_str_mv | openAccess |
| format | article |
| id | LAURepo_8e111cc2fc356c42f5ef5cd4c3c6ddb8 |
| identifier_str_mv | 1473-2300 Bohlega, S., Alsaadi, T., Amir, A., Hosny, H., Karawagh, A. M., Moulin, D., ... & Shelbaya, S. (2010). Guidelines for the pharmacological treatment of peripheral neuropathic pain: expert panel recommendations for the middle East region. Journal of International Medical Research, 38(2), 295-317. |
| language_invalid_str_mv | en |
| network_acronym_str | LAURepo |
| network_name_str | Lebanese American University repository |
| oai_identifier_str | oai:laur.lau.edu.lb:10725/10511 |
| publishDate | 2010 |
| repository.mail.fl_str_mv | |
| repository.name.fl_str_mv | |
| repository_id_str | |
| spelling | Guidelines for the pharmacological treatment of peripheral neuropathic painexpert panel recommendations for the middle east regionRiachi, N.Bohlega, S.Alsaadi, T.Amir, A.Hosny, H.Karawagh, A.M.Moulin, D.Salti, A.Shelbaya, S.Neuropathic pain (NeP) has been the focus of extensive basic and clinical research over the past 20 years. This has led to an increased understanding of underlying pathophysiological mechanisms and the development of new therapeutic agents, as well as a clearer definition of the role of established medications. To date there are no published treatment guidelines for NeP in the Middle East. A multidisciplinary panel of Middle East and international experts met to review critically and reach a consensus on how best to apply evidence-based guidelines for the treatment of NeP (mainly peripheral NeP) in the Middle East. The expert panel recommended pregabalin, gabapentin and secondary amine tricyclic antidepressants (nortriptyline and desipramine) as first-line treatments for peripheral NeP. Serotonin-norepinephrine reuptake inhibitor antidepressants, tramadol and controlled-release opioid analgesics were recommended as second-line treatments. There is a need to increase diagnostic awareness of NeP, use validated screening questionnaires and undertake more treatment research in the Middle East region.PublishedN/A2019-04-30T12:53:14Z2019-04-30T12:53:14Z20102019-04-30Articleinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article1473-2300http://hdl.handle.net/10725/10511https://doi.org/10.1177/147323001003800201Bohlega, S., Alsaadi, T., Amir, A., Hosny, H., Karawagh, A. M., Moulin, D., ... & Shelbaya, S. (2010). Guidelines for the pharmacological treatment of peripheral neuropathic pain: expert panel recommendations for the middle East region. Journal of International Medical Research, 38(2), 295-317.http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.phphttps://journals.sagepub.com/doi/abs/10.1177/147323001003800201enJournal of International Medical Researchinfo:eu-repo/semantics/openAccessoai:laur.lau.edu.lb:10725/105112021-03-19T10:47:34Z |
| spellingShingle | Guidelines for the pharmacological treatment of peripheral neuropathic pain Riachi, N. |
| status_str | publishedVersion |
| title | Guidelines for the pharmacological treatment of peripheral neuropathic pain |
| title_full | Guidelines for the pharmacological treatment of peripheral neuropathic pain |
| title_fullStr | Guidelines for the pharmacological treatment of peripheral neuropathic pain |
| title_full_unstemmed | Guidelines for the pharmacological treatment of peripheral neuropathic pain |
| title_short | Guidelines for the pharmacological treatment of peripheral neuropathic pain |
| title_sort | Guidelines for the pharmacological treatment of peripheral neuropathic pain |
| url | http://hdl.handle.net/10725/10511 https://doi.org/10.1177/147323001003800201 http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php https://journals.sagepub.com/doi/abs/10.1177/147323001003800201 |